November is flu-season in Germany. Therefore the 5th biggest national Newspaper in Germany – Welt – got the great idea to present our research and the planned product in a big article in their “Knowledge” section of the printed version. Estimated 1.4 million readers are reached with the printed paper and the web services of … Read more
Tagesspiegel.de highlights, in an article, our success in winning a challenge by the SPRIND agency of the Federal Ministry of Education and Research of Germany, and introduces the unique mechanism of action of our nasal spray currently in development. This nasal spray presents a novel approach in the creation of antiviral agents. With a significant … Read more
The COVID-19 pandemic has highlighted the urgent need for antiviral agents, generating significant interest in related research. Tagesspiegel.de hits this spot by discussing the MucBoost research project, involving multiple partners and focusing on our new antiviral mechanism of action in a thorough article. With its extensive reach of 9.2 million unique users per month, tagesspiegel.de … Read more
Learn more about the science behind our nasal spray in this video. The YouTube channel “Breaking Lab” presents the team MucBoost and other teams of the challenge “broad-spectrum antivirals”, which was launched by SPRIND, the Federal Agency for Disruptive Innovation – Germany. The MucBoost project is one of the winners of the challenge’s second stage
The local newspaper “Der Teckbote” has an affectionate report about a son of the city Kirchheim unter Teck – Dr. Daniel Lauster. The founding of his research group at the Freie University of Berlin and his “unappetizing” research topics are reported in detail. As unappetizing – with a wink – they mention the general research … Read more
The newspage of the German Pharmacist Association (Pharmazeutische-Zeitung.de) features the the first level of the challenge „broad-spectrum antivirals“ by SPRIND – the Federal Agency for Disruptive Innovation – Germany with an article. Among the nine teams is the MucBoost project, from which MucosaTec GmbH is a spin-off. Pharmazeutische-Zeitung.de counted 3,470,205 page impressions and 1,733,170 visits … Read more
© COPYRIGHT MUCOSATEC
